DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence
A podcast by DrugPatentWatch
Categories:
100 Episodes
-
Indian Pharma—Some Challenges and Acceptances
Published: 12/21/2020 -
Essential Medicines and Patents
Published: 12/15/2020 -
Drug Patent Expirations for the Week of November 29, 2020
Published: 12/3/2020 -
New patent expiration for Cubist Pharms drug ENTEREG
Published: 11/29/2020 -
Thinking of signing your company up for DrugPatentWatch?
Published: 11/10/2020 -
Finding and Evaluating Generic Drug Market Entry Opportunities
Published: 10/6/2020 -
Freedom of Information Act Access to an Investigational New Drug Application
Published: 10/6/2020 -
Finding and Evaluating Generic Market Entry Opportunities
Published: 9/24/2020 -
Getting the most out of pharmaceutical patent-term extensions in Russia
Published: 9/22/2020 -
Switching to DrugPatentWatch
Published: 9/22/2020 -
Government as the First Investor in Biopharmaceutical Innovation
Published: 9/15/2020 -
Bloomberg and Drug PatentWatch: A “Perfect Storm” Affecting Generic Drugs
Published: 9/15/2020 -
Finding hidden treasures in old drugs: the challenges and importance of licensing generics
Published: 9/2/2020 -
Drug Repurposing: An Overview
Published: 8/19/2020 -
Investing in Drug Companies? Here are 6 Vital Non-Patent Factors to Consider
Published: 8/19/2020 -
Generic Drugs Approved but not Launched – How to Tell When Generic Drugs Will hit the Market
Published: 8/12/2020 -
Finding and Evaluating Market Entry Opportunities for a Better ROI
Published: 8/4/2020 -
Free Patent Litigation Docket Reports Data
Published: 7/30/2020 -
Free Orange Book PDF Library from DrugPatentWatch
Published: 7/24/2020 -
A comprehensive review of database resources in chemistry
Published: 7/16/2020
DrugPatentWatch serves leading companies ranging from biopharmaceutical R&D to healthcare delivery, and has been cited by CNN, NEJM, Nature Journals, and many other leading publications. Use cases for the DrugPatentWatch platform include: - Branded pharmaceutical global business intelligence and forecasting - Generic drug and API manufacturer portfolio management - Wholesalers preventing overstock of off-patent drugs - Healthcare payer formulary management and budget management